Loading stock data...

Ipca Laboratories Limited

NSE: IPCALAB BSE: IPCALAB

NSE
1,529.50 41.00 (2.75%)

Prev Close

1488.5

Open Price

1488

Volume

501,348

Today Low / High

1479.1 / 1560.5

52 WK Low / High

1168.2 / 1755.9

Range

1,453 - 1,606

BSE
1,529.40 39.80 (2.67%)

Prev Close

1489.6

Open Price

1489.55

Volume

18,117

Today Low / High

1479.25 / 1560

52 WK Low / High

1200 / 1757.65

Range

1,453 - 1,606

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1529.5 (target range: 1,453 - 1,606), reflecting a change of 41 (2.75445%). On the BSE, it is listed at 1529.4 (target range: 1,453 - 1,606), showing a change of 39.8 (2.67186%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

30 Jul 1,488.00 3.89%
29 Jul 1,482.00 0.44%
28 Jul 1,514.00 -2.06%
25 Jul 1,552.00 -2.77%
24 Jul 1,460.00 5.53%
23 Jul 1,460.20 -0.02%
22 Jul 1,470.00 -0.67%
21 Jul 1,471.00 -0.29%
18 Jul 1,474.10 -0.21%
17 Jul 1,473.00 0.07%
16 Jul 1,471.00 -0.63%
15 Jul 1,467.70 0.22%
14 Jul 1,449.60 0.50%
11 Jul 1,447.30 0.16%
10 Jul 1,455.00 -0.73%
09 Jul 1,465.00 -0.65%
08 Jul 1,462.00 0.22%
07 Jul 1,422.90 2.45%
04 Jul 1,415.70 0.50%
03 Jul 1,378.20 2.72%
02 Jul 1,380.00 -0.36%

Ipca Laboratories Limited Graph

Ipca Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Ipca Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,529.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,529.40 1,544.69 1,390.22 - 1,699.16
1,559.99 1,247.99 - 1,871.99
1,575.28 1,102.70 - 2,047.87
Bearish Scenario 1,529.40 1,514.11 1,362.70 - 1,665.52
1,498.81 1,199.05 - 1,798.57
1,483.52 1,038.46 - 1,928.57

Overview of Ipca Laboratories Limited

ISIN

INE571A01038

Industry

Drug Manufacturers - Specialty & Generic

Vol.Avg

315,270

Market Cap

392,480,088,000

Last Dividend

4

Official Website

Visit Website

IPO Date

1996-01-01

DCF Diff

-2,880.65

DCF

4,369

Financial Ratios Every Investor Needs

Stock Dividend of IPCALAB

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-08-05 August 05, 25 2 2 2025-08-05 2025-09-10
2024-11-27 November 27, 24 2 2 2024-11-27 2024-12-10
2024-08-06 August 06, 24 2 2 2024-08-06 2024-09-10
2023-11-22 November 22, 23 2 2 2023-11-22 2023-12-10
2022-11-22 November 22, 22 4 4 2022-11-23 2022-12-07

Stock Rating Details for IPCALAB

Metric Value Recommendation
Overall Rating B Neutral
DCF Score 5 Strong Buy
ROE Score 4 Buy
ROA Score 4 Buy
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 8,939.59 Cr 5,160.36 Cr 3,779.23 Cr 0.4228 0.00 Cr 0.00 Cr 1,328.32 Cr 737.68 Cr 29.07 1,613.89 Cr 0.0825
2024-03-31 7,622.41 Cr 2,847.47 Cr 4,774.94 Cr 0.6264 170.71 Cr 117.40 Cr 2,959.65 Cr 547.35 Cr 21.57 1,329.95 Cr 0.0718
2023-03-31 6,244.32 Cr 2,407.51 Cr 3,836.81 Cr 0.6144 130.76 Cr 76.19 Cr 703.35 Cr 471.32 Cr 18.58 1,052.66 Cr 0.0755
2022-03-31 5,766.46 Cr 2,105.97 Cr 3,660.49 Cr 0.6348 41.79 Cr 73.65 Cr 1,062.66 Cr 884.08 Cr 34.85 1,378.34 Cr 0.1533
2021-03-31 5,420.73 Cr 1,801.76 Cr 3,618.97 Cr 0.6676 121.35 Cr 97.07 Cr 1,314.59 Cr 1,140.01 Cr 45.01 1,609.40 Cr 0.2103

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 344.23 Cr 11,760.55 Cr 3,372.28 Cr 6,948.4500 Cr 1,362.74 Cr 1,018.51 Cr 2,560.42 Cr 4,685.34 Cr 0.00 Cr 0.00 Cr 348.56 Cr 2,386.2200 Cr
2024-03-31 208.91 Cr 11,101.28 Cr 3,374.28 Cr 6,332.1900 Cr 1,438.36 Cr 1,229.45 Cr 2,469.56 Cr 4,696.18 Cr 16.87 Cr 0.12 Cr 303.61 Cr 2,355.6400 Cr
2023-03-31 1,257.85 Cr 8,626.43 Cr 2,711.11 Cr 5,842.0200 Cr 1,481.27 Cr 223.42 Cr 1,743.37 Cr 2,694.58 Cr 27.40 Cr 0.28 Cr 302.66 Cr 1,805.8200 Cr
2022-03-31 275.19 Cr 7,623.53 Cr 2,081.77 Cr 5,491.8700 Cr 807.22 Cr 532.03 Cr 1,857.97 Cr 2,502.59 Cr 26.77 Cr 0.54 Cr 269.88 Cr 1,465.8800 Cr
2021-03-31 165.97 Cr 6,068.36 Cr 1,352.18 Cr 4,701.6500 Cr 265.39 Cr 99.42 Cr 1,594.81 Cr 2,146.45 Cr 20.85 Cr 0.59 Cr 111.43 Cr 1,160.5400 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 1,275.1000 Cr -893.5000 Cr -212.7600 Cr 499.5300 Cr 0.0000 Cr 344.2300 Cr -775.5700 Cr 737.6800 Cr -93.2500 Cr -101.4800 Cr -91.5600 Cr
2024-03-31 944.6500 Cr -1,291.7900 Cr -552.5500 Cr 533.3600 Cr -823.1900 Cr 755.7900 Cr -410.6000 Cr 547.3500 Cr -356.8800 Cr -50.7400 Cr -92.9500 Cr
2023-03-31 805.8100 Cr -725.0000 Cr 507.2400 Cr 311.3400 Cr 588.0500 Cr 1,578.9800 Cr -494.4700 Cr 745.2900 Cr 657.7100 Cr -101.4800 Cr 114.6000 Cr
2022-03-31 856.0400 Cr -855.0500 Cr 426.7800 Cr 377.1200 Cr 431.9200 Cr 990.9300 Cr -478.9500 Cr 1,135.7200 Cr 540.3200 Cr -101.4800 Cr -249.1500 Cr
2021-03-31 1,090.1300 Cr -520.6900 Cr -305.8200 Cr 728.5800 Cr 263.6200 Cr 559.0100 Cr -361.5500 Cr 1,381.2800 Cr -225.7900 Cr -101.5300 Cr -271.6900 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 2,246.69 Cr 1,309.25 Cr 937.44 Cr 0.4173 328.74 Cr 67.82 Cr 2.67 249.63 Cr 0.0302
2024-12-31 2,245.37 Cr 668.21 Cr 1,577.16 Cr 0.7024 364.62 Cr 248.14 Cr 9.78 483.19 Cr 0.1105
2024-09-30 2,354.90 Cr 758.56 Cr 1,596.34 Cr 0.6779 341.13 Cr 229.48 Cr 9.05 467.74 Cr 0.0974
2024-06-30 2,092.63 Cr 643.49 Cr 1,449.14 Cr 0.6925 293.83 Cr 192.24 Cr 7.58 413.33 Cr 0.0919
2024-03-31 2,033.01 Cr 1,250.03 Cr 782.98 Cr 0.3851 98.15 Cr 59.59 Cr 2.35 204.10 Cr 0.0293

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 344.23 Cr 763.39 Cr 1,107.62 Cr 1,916.58 Cr 2,560.42 Cr 5,967.04 Cr 4,685.34 Cr 11,760.55 Cr 3,372.28 Cr
2024-12-31 0.00 Cr 0.00 Cr 903.23 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -8,117.66 Cr
2024-09-30 255.94 Cr 688.69 Cr 944.63 Cr 0.00 Cr 2,518.31 Cr 5,680.69 Cr 4,776.43 Cr 11,423.77 Cr 3,306.11 Cr
2024-06-30 0.00 Cr 0.00 Cr 854.26 Cr 0.00 Cr 0.00 Cr 854.26 Cr 0.00 Cr 0.00 Cr -7,727.00 Cr
2024-03-31 208.91 Cr 636.44 Cr 845.35 Cr 1,694.61 Cr 2,469.56 Cr 5,538.90 Cr 4,663.10 Cr 11,101.28 Cr 3,374.28 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 248.14 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 229.48 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 192.24 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 59.59 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 179.88 Cr 199.00 Cr 0.00 Cr 0.00 Cr 199.00 Cr 697.77 Cr 498.77 Cr 0.00 Cr 199.00 Cr

Splits History

Date Label Split Ratio
2022-01-10 January 10, 22 2:1
2010-03-22 March 22, 10 5:1
2005-01-28 January 28, 05 2:1

Similar Stocks: Drug Manufacturers - Specialty & Generic

Company Name Symbol Price Market Cap Volume
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,733.80 ₹4,159,871,664,000.00 ₹2,318,664.00
Divi's Laboratories Limited DIVISLAB ₹6,650.00 ₹1,765,368,850,000.00 ₹226,973.00
Torrent Pharmaceuticals Limited TORNTPHARM ₹3,730.60 ₹1,262,602,917,000.00 ₹439,520.00
Dr. Reddy's Laboratories Limited DRREDDY ₹1,292.10 ₹1,075,456,274,108.00 ₹1,386,961.00
Mankind Pharma Limited MANKIND ₹2,575.50 ₹1,062,982,921,380.00 ₹763,328.00
Zydus Lifesciences Limited ZYDUSLIFE ₹995.15 ₹1,001,349,784,500.00 ₹775,382.00
Lupin Limited LUPIN ₹1,984.60 ₹906,460,096,200.00 ₹754,124.00
Aurobindo Pharma Limited AUROPHARMA ₹1,158.00 ₹672,568,716,000.00 ₹672,249.00
Alkem Laboratories Limited ALKEM ₹5,099.60 ₹609,733,674,000.00 ₹69,765.00
Glenmark Pharmaceuticals Limited GLENMARK ₹2,153.60 ₹607,748,073,600.00 ₹786,090.00
Laurus Labs Limited LAURUSLABS ₹881.45 ₹475,603,095,050.00 ₹5,551,173.00
Suven Pharmaceuticals Limited SUVENPHAR ₹1,078.00 ₹412,407,234,624.00 ₹1,177,218.00
Ipca Laboratories Limited IPCALAB ₹1,529.50 ₹388,040,268,000.00 ₹501,348.00
Cohance Lifesciences Limited COHANCE ₹997.40 ₹381,572,333,779.00 ₹30,739.00
Ajanta Pharma Limited AJANTPHARM ₹2,800.50 ₹349,816,056,000.00 ₹68,739.00
Piramal Enterprises Limited PEL ₹1,287.60 ₹291,870,592,800.00 ₹4,377,271.00
J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM ₹1,782.60 ₹278,652,466,800.00 ₹198,162.00
Wockhardt Limited WOCKPHARMA ₹1,684.80 ₹273,744,619,200.00 ₹253,355.00
Eris Lifesciences Limited ERIS ₹1,816.60 ₹247,415,470,200.00 ₹258,998.00
AstraZeneca Pharma India Limited ASTRAZEN ₹9,340.00 ₹233,500,000,000.00 ₹39,783.00
Alembic Pharmaceuticals Limited APLLTD ₹1,007.60 ₹198,056,878,800.00 ₹43,245.00
Jubilant Pharmova Limited JUBLPHARMA ₹1,236.30 ₹196,919,100,300.00 ₹1,978,762.00
Neuland Laboratories Limited NEULANDLAB ₹13,910.00 ₹178,463,909,000.00 ₹72,265.00
NATCO Pharma Limited NATCOPHARM ₹973.15 ₹174,300,896,500.00 ₹709,365.00
Caplin Point Laboratories Limited CAPLIPOINT ₹2,145.80 ₹163,105,905,860.00 ₹121,630.00
Glenmark Life Sciences Limited GLS ₹1,086.00 ₹133,070,838,000.00 ₹130,938.00
Granules India Limited GRANULES ₹492.15 ₹119,417,244,600.00 ₹954,418.00
Procter & Gamble Health Limited PGHL ₹5,947.00 ₹98,716,631,800.00 ₹41,877.00
Shilpa Medicare Limited SHILPAMED ₹919.15 ₹89,884,505,735.00 ₹41,687.00
Strides Pharma Science Limited STAR ₹945.35 ₹87,126,008,445.00 ₹401,712.00
Aarti Pharmalabs Limited AARTIPHARM ₹946.50 ₹85,785,667,830.00 ₹174,284.00
FDC Limited FDC ₹484.45 ₹78,873,304,500.00 ₹30,593.00
Suven Life Sciences Limited SUVEN ₹269.30 ₹58,727,328,200.00 ₹85,394.00
Innova Captab Limited INNOVACAP ₹917.50 ₹52,503,873,275.00 ₹36,415.00
Sun Pharma Advanced Research Company Limited SPARC ₹151.93 ₹49,304,627,460.00 ₹195,988.00
Aarti Drugs Limited AARTIDRUGS ₹522.25 ₹47,665,757,500.00 ₹446,949.00
Sequent Scientific Limited SEQUENT ₹175.86 ₹44,023,913,100.00 ₹235,318.00
Unichem Laboratories Limited UNICHEMLAB ₹619.85 ₹43,641,035,130.00 ₹39,695.00
Hikal Limited HIKAL ₹329.80 ₹40,664,669,800.00 ₹316,649.00
Gufic Biosciences Limited GUFICBIO ₹404.55 ₹40,567,464,900.00 ₹352,761.00
RPG Life Sciences Limited RPGLIFE ₹2,405.80 ₹39,789,526,200.00 ₹52,499.00
Orchid Pharma Limited ORCHPHARMA ₹705.15 ₹35,764,573,365.00 ₹37,012.00
Morepen Laboratories Limited MOREPENLAB ₹59.69 ₹32,707,374,260.00 ₹1,444,289.00
Solara Active Pharma Sciences Limited SOLARA ₹651.90 ₹31,390,940,700.00 ₹124,331.00
Indoco Remedies Limited INDOCO ₹324.50 ₹29,934,443,550.00 ₹64,322.00
IOL Chemicals and Pharmaceuticals Limited IOLCP ₹100.29 ₹29,437,822,830.00 ₹15,953,556.00
Alembic Limited ALEMBICLTD ₹114.24 ₹29,334,775,566.00 ₹212,418.00

Key Executives

President of Marketing
Mr. Sunil Ghai

Gender: male

Year Born: 1963

President of Human Resources
Mr. Saidutta Nanda

Gender: male

Year Born:

Chief Executive Officer, MD & Executive Director
Mr. Pranay Premchand Godha

Gender: male

Year Born: 1972

Compliance Officer, Corporate Counsel & Company Secretary
Mr. Harish Pandurang Kamath

Gender: male

Year Born: 1959

Vice President of Operations
Mr. Pawan Kothari

Gender: male

Year Born: 1965

Vice President of Technical
Mr. Vishnu Saran Singh Kushwaha

Gender: male

Year Born: 1968

President of R&D - Chemicals
Dr. Ashok Kumar

Gender: Not Specified

Year Born: 1954

Executive Director
Mr. Prashant Premchand Godha

Gender: male

Year Born: 1975

Executive Chairman
Mr. Premchand Godha A.C. A., B. Com., CA

Gender: male

Year Born: 1946

Chief Financial Officer, MD & Executive Director
Mr. Ajit Kumar Bhanwarlal Jain A.C.A., B.Sc.

Gender: male

Year Born: 1955

FAQs about Ipca Laboratories Limited

Who is the CEO of the company?

The CEO is Pranay Premchand Godha.

What is the current market price of the stock?

The current price is ₹1,547.00.

What is the 52-week price range?

The range is ₹1168.2-1755.9.

What is the market capitalization of the company?

The market capitalization is ₹39,248.01 crores.

What is the dividend yield?

The dividend yield is 0.26%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 53.19.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Ipca Laboratories Limited (ISIN: INE571A01038) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹39,248.01 crores and an average daily volume of 315,270 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹4.